SCHEMBL7270433

SCHEMBL7270433

CC(C)[C@H](N)C(=O)N(C(=O)NCc1ccccn1)C(Cc1ccccc1)C(O)C(Cc1ccccc1)N(C(=O)NCc1ccccn1)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
MAPT P10636 1/20 0.56
CA2 P00918 2/20 0.47
POLB P06746 2/20 0.46
ALDH1A1 P00352 4/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269984 0.88 ALDH1A1 (0.41) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL7270435 0.84 L3MBTL1 (0.47) SMN1; SMN2CYP1A2POLBALDH1A1HPGD
SCHEMBL7269409 0.83 CYP1A2 (0.45) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL7278089 0.82 CA2 (0.53) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL6449597 0.82 CYP1A2 (0.44) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL7275895 0.82 PGR (0.47) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL6449059 0.82 PGR (0.46) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL6449591 0.82 CA2 (0.52) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL6445021 0.82 PGR (0.46) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT
SCHEMBL6447678 0.82 PGR (0.46) TSHRSMN1; SMN2CYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed